| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
BiomX (AMEX:PHGE) is gearing up to announce its quarterly earnings on Wednesday, 2025-08-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that BiomX will report an earnings per share (EPS) of $-0.29.
The market awaits BiomX's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
The company's EPS missed by $0.03 in the last quarter, leading to a 4.2% drop in the share price on the following day.
Here's a look at BiomX's past performance and the resulting price change:
| Quarter | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.30 | -1.10 | ||
| EPS Actual | -0.33 | -0.91 | -0.31 | -0.7 |
| Price Change % | -4.0% | -11.0% | -17.0% | -12.0% |
Shares of BiomX were trading at $0.55 as of August 11. Over the last 52-week period, shares are down 69.21%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
To track all earnings releases for BiomX visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: PHGE
